SLENYTO® (melatonin extended-release tablets) is now available in Canada as a prescription treatment for insomnia in children and adolescents with autism spectrum disorder (ASD) and/or Smith-Magenis syndrome (SMS).

Bioxytran Reports Encouraging Clinical Observations in First Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Patient Treated with PLICID, a Novel Galectin Antagonist Designed with Artificial Intelligence

Gain Therapeutics Reports Financial Results for Second Quarter 2026 and Provides Corporate Update

数千位药企董事长/总经理等决策层已报名！最新名单公布！制药人免费！

四款大单品，被暂停采购三个月！